The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Pharmacogenetic determinants of sunitinib-induced toxicity in Korean patients with metastatic renal cell carcinoma.
H. R. Kim
No relevant relationships to disclose
W. S. Kwon
No relevant relationships to disclose
L. Gui Youn
No relevant relationships to disclose
J. R. Ahn
No relevant relationships to disclose
H. J. Park
No relevant relationships to disclose
H. S. Kim
No relevant relationships to disclose
S. J. Shin
No relevant relationships to disclose
J. B. Ahn
No relevant relationships to disclose
S. Y. Rha
No relevant relationships to disclose